Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / TLIS - Talis Biomedical appoints former Abbott executive as CEO

TLIS - Talis Biomedical appoints former Abbott executive as CEO

Talis Biomedical Corporation
Talis Biomedical Corporation (NASDAQ:TLIS) posted better-than-expected revenue for Q3 2021 and announced its latest leadership change with the earnings release. The company has appointed Brian Blaser to President, Chief Executive Officer, and Director, replacing the interim CEO Kim Popovits who will resume the role as director of the board. The leadership change will take place on Dec. 01. “With the recent Emergency Use Authorization for our Talis One™ COVID-19 Test System, our experienced executive leadership, and Brian’s industry expertise, we are well positioned to address a significant and growing unmet need in infectious disease testing,” Popovits remarked. A 25-year veteran in the in-vitro diagnostics industry, Mr. Blaser most recently served as EVP of Diagnostics Products at Abbott (NYSE:ABT). In August, Talis (TLIS) announced the departure of former CEO Brian Coe with immediate effect.

For further details see:

Talis Biomedical appoints former Abbott executive as CEO
Stock Information
Company Name: Talis Biomedical Corporation
Stock Symbol: TLIS
Market: NASDAQ
Website: talis.bio
Menu
TLIS TLIS Quote TLIS Short TLIS News TLIS Articles TLIS Message Board
Get TLIS Alerts

News, Short Squeeze, Breakout and More Instantly...